Bone Marrow Mesenchymal Stem Cells Suppress Lymphocyte Proliferation in Vitro but Fail to Prevent Graft-versus-host Disease in Mice.
From: Biologie et Thérapeutique des Pathologies Immunitaires Université Pierre et Marie Curie/Centre National de la Recherche Scientifique Unité Mixte de Recherche 7087, Paris, France.
Journal of immunology (Baltimore, Md. : 1950)
- Publish Date: Jun 2006
- ISSN: 0022-1767
- Volume: 176
- Issue: 12
- Pages: 7761-7
- Medium: Print
- Language: English
- Citation (JAMA): Sudres Muriel, Norol Françoise, Trenado Aurélie, et al. Bone Marrow Mesenchymal Stem Cells Suppress Lymphocyte Proliferation in Vitro but Fail to Prevent Graft-versus-host Disease in Mice.. J. Immunol. Jun 2006;176:7761-7
Abstract
Several reports have suggested that mesenchymal stem cells (MSCs) could exert a potent immunosuppressive effect in vitro, and thus may have a therapeutic potential for T cell-dependent pathologies. We aimed to establish whether MSCs could be used to control graft-vs-host disease (GVHD), a major cause of morbidity and mortality after allogeneic hemopoietic stem cell transplantation. From C57BL/6 and BALB/c mouse bone marrow cells, we purified and expanded MSCs characterized by the lack of expression of CD45 and CD11b molecules, their typical spindle-shaped morphology, together with their ability to differentiate into osteogenic, chondrogenic, and adipogenic cells. These MSCs suppressed alloantigen-induced T cell proliferation in vitro in a dose-dependent manner, independently of their MHC haplotype. However, when MSCs were added to a bone marrow transplant at a MSCs:T cells ratio that provided a strong inhibition of the allogeneic responses in vitro, they yielded no clinical benefit on the incidence or severity of GVHD. The absence of clinical effect was not due to MSC rejection because they still could be detected in grafted animals, but rather to an absence of suppressive effect on donor T cell division in vivo. Thus, in these murine models, experimental data do not support a significant immunosuppressive effect of MSCs in vivo for the treatment of GVHD.
Mesh Headings (Keywords): Animals, Bone Marrow Transplantation, Cell Proliferation, Cell Separation, Cells, Cultured, Disease Models, Animal, Female, Graft Rejection, Graft vs Host Disease, Immunophenotyping, Immunosuppression, Lymphocyte Culture Test, Mixed, Lymphocytes, Mesenchymal Stem Cell Transplantation, Mice, Mice, Inbred BALB C, Mice, Inbred C57BL, Mice, Transgenic, Radiation Chimera, Spleen
Check for Full Text / PubMed Unique Identifier (PMID): 16751424
This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.
Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.
The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.